Risk of Nephropathy From Radiocontrast Overestimated

This article originally appeared here.
Share this content:
Risk of Nephropathy From Radiocontrast Overestimated
Risk of Nephropathy From Radiocontrast Overestimated

THURSDAY, Oct. 13, 2016 (HealthDay News) -- The risk of radiocontrast-associated nephropathy may be overestimated, according to a study published online Sept. 29 in the Journal of the American Society of Nephrology.

Emilee Wilhelm-Leen, M.D., from Stanford University in Palo Alto, Calif., and colleagues used data from the Nationwide Inpatient Sample to estimate the risk of radiocontrast-associated nephropathy among adult patients hospitalized in the United States in 2009.

The researchers found that patients who received radiocontrast did not develop acute kidney injury (AKI) at clinically significant higher rates. Adjusted only for the complex survey design, patients receiving radiocontrast developed AKI at 5.5 percent, versus 5.6 percent in patients to whom radiocontrast was not administered. Radiocontrast administration was associated with an odds ratio for AKI of 0.93 when controlling for comorbidity and acuity of disease.

"More accurate AKI risk estimates may improve clinical decision-making when attempting to balance the potential benefits of radiocontrast-enhanced imaging and the risk of AKI," the authors write.

Abstract
Full Text (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!

Already a member?

Sign In Now »

Drug Lookup

Browse drugs by: BrandGenericDisease

Trending Activities

All Professions



Sign up for myCME e-newsletters


More in Home

AAP: Congress Urged to Act to Prevent Firearm Deaths

AAP: Congress Urged to Act to Prevent Firearm ...

Following latest shooting, pediatricians join call for action to be taken to address firearm deaths, injury

Lung Cancer Incidence Higher for Young Women Than Young Men

Lung Cancer Incidence Higher for Young Women Than ...

Crossover in sex-specific rates among U.S. non-Hispanic whites born since 1965

E-Cigarette Flavoring Agent May Impair Airway Defense System

E-Cigarette Flavoring Agent May Impair Airway Defense System

Flavoring commonly used in e-cigarettes suppresses cilia beat frequency, lasting for 60 minutes

is free, fast, and customized just for you!

Already a member?

Sign In Now »